After all the plans and attention, life seems to be unpredictable at one stage or another stage! And, in most cases, when an individual is facing a health crisis, most of the diseases at hand are chronic and irreversible. Humans try to protect the health of children and loved ones in many ways. One method that has become increasingly popular with its success rate is umbilical cord blood stem cell transplantation. Today, it is thought to be a remedy for miracles for diseases that the doctor previously thought was stalled.
The use of UCB (Umbilical Cord Blood) as an abundant source of umbilical cord blood stem cells is expanding over the past decade. Today, it is a successful exercise to treat children already suffering from hematological malignancies. In addition, there is also the use of dual UCB and minimum intensity implantation platform which also contributes to this expansion. Recently, researchers are studying resist - based evaluation and end - to - end multicenter and single - center clinical trials to make UCB transplant more receptive. The aim is to cope with complicated diseases such as sickle cell disease and costman syndrome and to successfully treat transplant without side effects.
When a baby is born, umbilical cord blood is collected from placenta and umbilical cord. The collection process is very easy, there is no danger to babies and mothers. These umbilical cord blood cells contain hematopoietic stem cells (HSCs), which are typically rare cells also found in bone marrow.
Hematopoietic stem cells are said to have the capacity to produce all kinds of cells in the blood such as white blood cells, red blood cells and platelets. They are responsible for maintaining blood production throughout their lives. And they have also been used for several years in bone marrow transplantation to treat blood related diseases. In addition, there are numerous reports suggesting that umbilical cord blood may also contain other cells not belonging to the blood, such as certain types of stem cells capable of producing neural cells. Such ideas and theories are open to discussion and are studied for correct verification.
Recently, more than 6000 patients worldwide are being treated with stem cell transplantation. The US Food and Drug Administration (FDA) examines this process experimentally and believes that the scope of future expertise is urgent. However, doctors usually raise umbilical cord blood from a child whose parents decided to store umbilical cord blood. At the time of transplant, if the patient and the donor have genetic similarities, the patient's body will accept blood transfusions.
According to Mary Laughlin of Cord Blood Transplantation Expert in Case Western Reserve University, Ohio, Cleveland, Ohio, all the reactions and reactions occurring between the recipient and donor cells are constant and all patients and doctors wanted donor cells to win I am sure. Typically, stem cell transplantation considers other processes, such as bone marrow transplantation, more tolerant, even if the donors do not completely match.
Because volunteer stem cell donor band has growth, patients needing it get close to getting the best match and opportunity for recovery increases. According to the Umbilical Blood Center in Minneapolis, Minnesota, the largest cord blood donation bank in the United States, the chance to win today's perfect or nearly perfect match has increased dramatically in the past four years.
Therefore, leukemia umbilical cord blood stem cell transplantation successfully handled all of beta, thalassassia, major, hereditary erythrocyte abnormality, pure erythropoietic dysplasia, multiple myeloma to plasma cells. And its future is a promising research that medical specialists are studying about the treatment of other chronic diseases at UCB.
